Intraoperative Molecular Margin Analysis in Head and Neck Cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 1, 2004, Pages 39-44

  Goldenberg, David ^a   Harden, Susan ^a   Masayesva, Brett G ^a   Ha, Patrick ^a   Benoit, Nicole ^a   Westra, William H ^a   Koch, Wayne M ^a   Sidransky, David ^a   Califano, Joseph A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Departments of Pediatrics Medicine Oncology and Radiation Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16;

ARTICLE; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; METHYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; QUANTITATIVE METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA, NEOPLASM; GENES, P16; HEAD AND NECK NEOPLASMS; HUMANS; INTRAOPERATIVE PERIOD; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SENSITIVITY AND SPECIFICITY;

EID: 0346374637     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.1.39     Document Type: Article

References (33)

1. Gandour-Edwards RF, Donald PJ, Wiese DA. Accuracy of intraoperative frozen section diagnosis in head and neck surgery: experience at a university medical center. Head Neck. 1993;15:33-38.
2. Looser KG, Shah JP, Strong EW. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978;1:107-111.
3. Batsakis JG. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol. 1999;6:140-148.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
5. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:429-435.
6. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477-4480.
7. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992;7:1159-1166.
8. Nathan CA, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope. 2002;112:2129-2140.
9. Nathan CA, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J. Analysis of surgical margins with the molecular marker elF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol. 1999;17:2909-2914.
10. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196.
11. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427-5440.
12. Okami K, Wu L, Riggins G, et al. Analysis of PTEN/MMAC1 alterations in aero-digestive tract tumors. Cancer Res. 1998;58:509-511.
13. Gleich LL, Salamone FN. Molecular genetics of head and neck cancer. Cancer Control. 2002;9:369-378.
14. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS-1/ in human cancers. Nat Med. 1995;1:686-692.
15. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630-3633.
16. Papadimitrakopoulou V, Izzo J, Lippman SM, et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 1997;14:1799-1803.
17. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 1999;59:793-797.
18. 6-alkylguanine. FASEB J. 1992;6:2302-2310.
19. 6-alkylguanine-DNA alkyltransferase activity in human colon cancer. Clin Cancer Res. 1995;1:519-525.
20. 6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues. J Natl Cancer Inst. 1992;84:337-340.
21. 6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem. 1994;269:17228-17237.
22. 6-methylguanine-DNA methyltransferase gene. Cancer Res. 1997;57:3672-3677.
23. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol. 1997;17:5612-5619.
24. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939-942.
25. Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000;60:892-895.
26. Capone RB, Pai SI, Koch WM, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 2000;6:4171-4175.
27. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
28. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88:7276-7280.
29. Davidson TM, Nahum AM, Astarita RW. Microscopic controlled excisions for epidermoid carcinoma of the head and neck. Otolaryngol Head Neck Surg. 1981;89:244-251.
30. Gath HJ, Brakenhoff RH. Minimal residual disease in head and neck cancer. Cancer Metastasis Rev. 1999;18:109-126.
31. Partridge M. Oral cancer, 2: clinical presentation and use of new knowledge about the biology of cancer to establish why tumours may recur. Dent Update. 2000;27:288-294.
32. Cepheid technology: solving the problem of DNA analysis. Cepheid Web site. Available at: http://www.cepheid.com/pages/tech.html. Accessed October 15, 2003.
33. Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2002;2:485-495.